Drug Database
Back to search

Netherlands· NL-aa682205ca87

Jaypirca 50 mg filmomhulde tabletten

A pirtobrutinib product containing pirtobrutinib, registered in Netherlands by Eli Lilly Nederland B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC L01EL05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedJaypirca 50 mg filmomhulde tablettenATCL01EL05REGISTER NO.NL-aa682205ca87PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pirtobrutinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pirtobrutinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L01EL05 (pirtobrutinib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search pirtobrutinib products by name

Pirtobrutinib · ATC L01EL05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pirtobrutinib costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.20 in France to $369.10 in Switzerland — a ×1801 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pirtobrutinib · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$369.10
  • FR France$0.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PIRTOBRUTINIB
Manufacturer
Eli Lilly Nederland B.V.
Country
Netherlands (NL)
ATC code
L01EL05
ATC class
Pirtobrutinib
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/23/1738

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pirtobrutinib in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pirtobrutinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Jaypirca
  • Liechtenstein · Jaypirca
  • Norway · Jaypirca

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/440e6e4c-5647-4157-b6d9-87161fc2fc22
GET /v1/drugs/440e6e4c-5647-4157-b6d9-87161fc2fc22?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/jaypirca-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Pirtobrutinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130072",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSEACETAATSUCCINAAT",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE, GEHYDRATEERD (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "PIRTOBRUTINIB"
  ],
  "leaflet_url": null,
  "authorised_at": "2023/10/30",
  "procedure_number": "EMEA/H/C/005863",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/23/1738",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about pirtobrutinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console